Diffusion magnetic resonance imaging of breast lesions: Initial experience at Alexandria University  by Hassan, Hebatallah Hassan Mamdouh et al.
Alexandria Journal of Medicine (2013) 49, 265–272Alexandria University Faculty of Medicine
Alexandria Journal of Medicine
www.sciencedirect.comORIGINAL ARTICLEDiﬀusion magnetic resonance imaging of breast
lesions: Initial experience at Alexandria UniversityHebatallah Hassan Mamdouh Hassan a,*, Mohamed Hamdy Mahmoud Zahran a,
Hassan El-Prince Hassan a, Alaa-Eldin Mohamed Abdel-Hamid a,
Gilan Abdel Shafy Fadaly ba Department of Radiodiagnosis, Faculty of Medicine, University of Alexandria, Egypt
b Department of Pathology, Medical Research Institute, University of Alexandria, EgyptReceived 3 October 2012; accepted 25 November 2012
Available online 31 March 2013A
di
C
pr
re
*
Fl
E
ho
Za
al
gm
Pe
M
20
htKEYWORDS
Apparent diffusion
coefﬁcient;
Breast;
Diffusion-weighted MRI;
Magnetic resonance
mammography;
MRM;
Positive predictive valuebbreviations: MRM, magne
ffusion weighted imaging;
C, cranio-caudal; MLO, m
edictive value; DCE-MRI,
sonance imaging
Corresponding author. Pre
oor, San Stefano, Alexandria
-mail addresses: hebaha
tmail.com (H.H.M. Hassan)
hran), Hassan.prince1@g
aadinmostafa@yahoo.com (A
ail.com (G. Abdel Shafy Fa
er review under responsibilit
edicine.
Production an
90-5068 ª 2013 Production
tp://dx.doi.org/10.1016/j.ajmtic reson
ADC, ap
edio-lat
dynamic
sent addr
, Egypt.
ssan13@
, mhzahra
mail.com
.-E. Moh
daly).
y of Ale
d hostin
and hosti
e.2012.11Abstract Objective: The purpose of our study was to investigate whether adding diffusion
weighted imaging (DWI) to dynamic contrast-enhanced MRI (DCE-MRI) could improve speciﬁc-
ity and the positive predictive value (PPV) of breast MRI in differentiating benign and malignant
focal breast mass lesions.
Materials and methods: The prospective study included 71 females with 103 focal breast lesions on
DCE-MRI who underwent subsequent biopsy. DWI was acquired during diagnostic breast MRI
using b= 0, 400 and 800 s/mm2. Apparent diffusion coefﬁcient (ADC) values were compared for
benign and malignant lesions. Sensitivity and PPV were calculated for DCE-MRI alone (based
on biopsy recommendations) and DCE-MRI plus DWI (adding an ADC threshold) for the same
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266 H.H.M. Hassan et al.Results: On pathological basis, 57 out of 103 focal lesions were benign and the remaining
revealed, 45 were malignant and one borderline. Malignant lesions exhibited lower mean
ADC (<1.3 · 103 mm2/s) than benign lesions (>1.3 · 103 mm2/s). Applying an ADC thresh-
old of 1.3 · 103 mm2/s sensitivity increased (on conventional DCE-MRI basis) from 86.95% up
to 93.47% and the speciﬁcity from 91.22% to 96.49% in detection of malignancy with PPV of
95.55% in comparison to 86.95% for enhancement kinetics alone, which would have avoided
biopsy for 10.5% (6/57) of benign lesions without missing any cancers.
Conclusion: DWI shows potential for improving the PPV of breast MRI for detection of malig-
nant breast lesions.
Recommendation: Furthermore, larger studies should be made to use it as a monitor for tumor
response to chemotherapy.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Alexandria University Faculty of Medicine.1. Introduction
Radiologists who practice breast imaging have long known
that the ﬁeld provides observational and interpretative chal-
lenges second to no other area of radiology. The discipline
of breast imaging is changing rapidly; the updates on the
state-of-the-art technology as well as fortifying the basic con-
cepts of breast imaging have been reﬁned and improved over
the prior 10–15 years.1
The medical imaging department at our institution, the
Alexandria University, has ﬁrst introduced the magnetic reso-
nance mammography (MRM) 5 years ago. Ever since, it has
been thoroughly under investigation particularly as it is an
important component of a still ongoing national breast imag-
ing program, which started in 2009 by screening for early
detection of breast cancer using digital mammography, with
special reﬂection on the population pool of the Alexandria
district.
Magnetic resonance mammography (MRM) is emerging as
an important tool for the detection and characterization of
breast cancer.2 Additional lesions seen by MRI that are not
visible on the mammogram have been reported to be present
between 27% and 37% of patients.3 This value is derived pri-
marily from the high sensitivity of contrast material enhance-
ment in the detection of breast cancer. Still, the
characterization of lesions as benign or malignant on the basis
of MR imaging characteristics remains a challenge.4,5
Studies in varying patient populations, using different
equipment, techniques, and interpretation criteria have yielded
sensitivities generally greater than 90%, but greatly varying
speciﬁcities.6–8 The improved sensitivity of MRI over conven-
tional imaging studies and clinical examination should allow
more accurate delineation of cancers and better treatment
planning. However, if the speciﬁcity is low, many additional
biopsies––with the added cost and needless patient anxiety––
will result.9
Diffusion weighted imaging (DWI), an MRI sequence,
explores the random motion of water molecules in the body.
Water molecules held in a container outside the body are in
constant random Brownian motion. This uninhibited motion
of water molecules is free from diffusion. By contrast, the
movement of water molecules in biologic tissues is restricted
because their motion is modiﬁed and limited by interactions
with cell membranes and macromolecules. The apparent dif-
fusion coefﬁcient (ADC) values are measured to estimate thedegree of diffusion. The degree of restriction to water diffu-
sion in biologic tissue is inversely correlated to the tissue cel-
lularity and the integrity of cell membranes. The motion of
water molecules is more restricted in tissues with a high cel-
lular density associated with numerous intact cell
membranes.10,11
Malignant lesions, in general, have more tightly packed
cells with a more compact architecture and, consequently, have
lower ADC values as compared with benign lesions. There is
inhibition of effective movement of water molecules and re-
stricted diffusion in dense malignant lesions. The higher
ADC values of cystic or necrotic areas reﬂect a lack of signif-
icant restriction of diffusion of water. False-negative values
can be obtained in cystic/necrotic malignancies.9,12–14
Measurement of the ADC provides a quantitative estimate
of the restrictive nature of the motion of water molecules with-
in tissue for each voxel in a diffusion-weighted image. Several
studies were designed to compare the ADC values between
malignant and benign lesions in the breast as well as to study
the change of ADC values in peri-tumor tissues, which would
be helpful for the clinical surgeon to decide the scope and pat-
tern of operation.15
Several attempts were made to quantify the ADC values
of benign and malignant breast lesions in order to use them
in conjunct with other criteria to reach a ﬁnal diagnosis, sev-
eral studies were done which concluded that the malignant
lesions had a mean ADC value of 1.2 ± 0.3 · 103 mm2/s
while benign lesions had an ADC value of
1.7 ± 0.5 · 103 mm2/s in comparison to the normal breast
tissue with ADC value of 2.1 ± 0.3 · 103 mm2/s. The wide
range of ADC values together with the overlap between cer-
tain entities of benign and malignant lesions makes it difﬁ-
cult to standardize a sharp cut off value, still there is a
consensus that an ADC of 1.2 or less is usually considered
malignant, while an ADC value of 1.5 and more is consid-
ered benign with the intervening range being an overlap that
can be considered as either according to the morphological
and kinetics of the lesion at hand.16–20
The aim of our study was to determine the feasibility of dif-
fusion weighted MRI sequence in increasing the MRM speci-
ﬁcity and positive predictive value in differentiating benign
and malignant focal breast mass lesions, thus alleviating the
unnecessary biopsy of benign lesions as well as patients with
equivocal post-therapy ﬁnding rather than undergoing the
stress of re-biopsy.
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2.1. Study population
Between January 2010 andDecember 2011, female patients who
presented to the Oncology and Onco-Surgery Departments in
the Alexandria Main University Hospital with suspected breast
lump were referred to the Radiodiagnosis Department and pro-
spectively assessed. The presence of a mass lesion had been sug-
gested by clinical assessment and further proved by
mammography and ultrasonography. Conventional DCE-
MRI detectedmass lesions in 71 patients with a total of 103mass
lesions; that were subjected to further assessment by DWI.
Lastly, histo-pathological analysis revealed 57 benign lesions,
45malignant lesions and one showing borderline result (ﬁbroad-
enoma with cellular atypia), among the studied 71 patients six
had mixed benign and malignant breast lesions. The females’
age range was between 15 and 70 years with a mean of 45 years,
with 51 newly diagnosed patients and 44 post-managed cases on
follow-up with suspected recurrence/de novo lesions. All fe-
males signed a formal consent before undergoing the procedure
and an approval from themedical ethics committee was attained
before starting the research.
2.2. Imaging techniques
For newly diagnosed lesions mammography with standard cra-
nio-caudal (CC) and medio-lateral oblique (MLO) views was
obtained for both breasts. In case of already managed patients
for breast cancer, the study was carried out accordingly, i.e. pa-
tients who underwent mastectomy, unilateral mammographic
CC and MLO views were attained for the contra-lateral breast,
while cases treated by lumpectomy or merely chemo- and radio-
therapy, bilateral mammographic images were obtained.
Sono-mammography was carried out according to the con-
dition at hand. It was performed either as a combination to
mammography especially in equivocal cases usually addressed
as BI-RADS 0 to reach a solid diagnosis prior to the magnetic
resonance mammography, or on a separate setting in patients
with a clear BI-RADS class based on mammographic ﬁndings.
2.3. MR imaging
Imaging was performed on a 1.5-T whole-body system;
Magnetom Avanto, Siemens Medical Solutions (Erlangen,
Germany), using a 4 channel phased array surface Breast
Matrix Coil. The patient laid prone on the MR table with
her breasts tightly ﬁtted in the coil. Before the patient’s
positioning, an IV line was secured into the patient’s arm,
maintained with saline and connected to an automated power
injector. Comfort of the patient is paramount. Every effort was
made to ensure it by head, arm and leg supports and pillows,
as this would improve compliance and prevent motion
especially between the pre- and post-contrast sets of images
avoiding mis-registration and sequence repetition hence reduc-
ing total scan time which was typically around 20 min.
2.4. Scanning protocols and parameters
The imaging protocol consisted of an initial rapid gradient-
echo scout localization sequence acquired in all three orthogo-nal planes through both breasts. Non-contrast sequences of
the breasts, axilla, and chest wall were acquired in the axial
plane notably: T2-weighted, fat saturated sequence with
TR = 5600, TE (59), FOV = 270–340 mm, acquisition ma-
trix = 320 \ 314, slice thickness = 4 mm and gap
20%= 0.8 mm in the axial plane. T1 – weighted, non-fat sat-
urated sequence with TR= 8.6, TE = 4.7, FOV= 270–340,
acquisition matrix = 448 \ 323, slice thickness = 1 mm and
gap 10%= 0.1 mm in the axial plane with trial to visualize
the axillae as our machine lacks a separate axillary coil. Diffu-
sion weighted echo-planar imaging (EPI) sequence is applied
before contrast administration with TR = 4800, TE = 98,
FOV= 270–340, matrix = 192 \ 192, slice thickness = 4 mm
and gap 50%= 2 mm in the axial plane, repeated with B-val-
ues 0, 400, 800 and automatically computer-generated ADC
map. This was followed by a 3D T1-weighted gradient-echo se-
quence performed before and repeated ﬁve times after the
intravenous administration of 0.2 mL of gadolinium chelate
per kilogram of the body weight. The initial non-contrast
phase with same parameters was acquired, to be used later
on for subtraction. The contrast was administered using an
automatic injector in a break of around 30 s. Post-contrast
imaging phase was initiated thereafter, 3D gradient-echo se-
quence with a repetition time of 60 s. Imaging was performed
with a 270–340 mm ﬁeld of view over a minimum matrix of
448 \ 322 and slice thickness of 1 mm or less with no gap
and an overlap of around 10%. The number of sections ac-
quired and the section thickness depended on the size of the
breast. The total imaging time for this acquisition was required
to be around 6.5 min. Fat suppression and image subtraction
were used in all cases. Automatically generated MIP images
in the axial, sagittal and coronal views as well as color coded
wash-in, wash-out and perfusion equilibrium images were ana-
lyzed as an aid in reaching the diagnosis in some cases.2.5. Image post-processing and interpretation
Image post processing techniques, using Syngo Siemens Med-
ical Solutions software, were applied for every breast MRI
exam, which adopted a systematic approach to review the
MRM studies consisting of two parts:
2.5.1 Analysis of the conventional MRI sequences comprising
both morphological and contrast dynamic curves. As a
start evaluation of the breasts and any detected lesions
was carried out. This included the lesion’s signal inten-
sity notably the T2 signal and fat content as well as its
shape and margins, followed by enhancement kinetics
analysis using the enhancement signal intensity versus
time curves by manually plotting a ROI on the enhanc-
ing lesions generating the type I progressive enhance-
ment, type II plateau and type III rapid wash in wash
out curve patterns.
2.5.2 Generating apparent diffusion coefﬁcient (ADC) maps
for assessment of lesion’s diffusion. The lesion was iden-
tiﬁed by comparing the contrast-enhanced MR images
and diffusion-weighted images, the ADC values of mass
or focal lesions were calculated accordingly. Since the
cut off value of diffusion restriction is still under inves-
tigation, we decided to use the most speciﬁc cut off value
for restriction till present which is ADC of 1.2 or less
Table 1 Enhancement pattern of detected focal lesions.
Benign Malignant Borderline Total
Type I curve 46 6 – 52
Type II curve – 2 – 2
Type III curve 5 33 1 39
Mix of 3 curves 1 4 5
Non-enhancing 5 – – 5
Total 57 45 1 103
268 H.H.M. Hassan et al.(usually considered malignant), ADC value of 1.5 and
more (considered benign) with the intervening range
being an overlap or borderline. Non-mass lesions were
excluded from the ADC analysis. The highest-signal
portion of the lesion was visually identiﬁed on high-
b-value images, and a circular region of interest (ROI)
was placed manually on that portion of the lesion.
The ﬁnal diagnosis was conﬁrmed by histo-pathological
analysis in all patients.
3. Results
Seventy-one cases had solid mass lesions with a total number
of 103 masses on MRI analysis in comparison to only 81 focal
masses on sonography (81/103 = 78.64%).Figure 1 Forty ﬁve years old female with the right breast asymmetry
well-deﬁned oval shaped lesion of probably benign nature, MRM conﬁ
T2 hyperintense right axillary tail lesion, (b) post-contrast subtracted im
no restriction with ADC value of 2.1 (>1.3 · 103 mm2/s).Morphological criteria were comparable on MRM and
sonography, for the enhancement kinetics 52 lesions with type
I progressive curve, 39 with washout type III curve and two le-
sions with type II curve, where a mix of all curve patterns is
seen in ﬁve out of the 98 enhancing mass lesions while the
remaining ﬁve lesions showed no preferential lesion enhance-
ment after contrast administration other than the normal sur-
roundings. Forty-six of the benign lesions had type I curve,
one had a mix of three curve types, while six had type III curve.
On the other hand six of the malignant lesions had type I
curve, two had type II, 33 had type III and four had a mix
of three curve types. The remaining borderline mass lesion
had type III curve. Type III wash in wash out pattern and to
a lesser extent type II plateau correlated with malignancy in
39/45 patients (Table 1).
Taking type III curve alone into consideration, obtained
sensitivity was 73.33%, speciﬁcity was 91.22% and positive
predictive value (PPV) was 86.95%, while adding type II pla-
teau or mixed curve patterns to detect malignancy sensitivity
rose up to 86.66%, while speciﬁcity went down to 89.47%
and PPV did not vary much being 86.84%.
Adding the diffusion weighted imaging technique, all the
examined lesions showed ADC values ranging from 0.5 to
3 · 103 cm2/s. Forty-ﬁve lesions displayed restricted diffusion
with a range from 0.5 to 1.2 · 103 cm2/s. Borderline restric-
tion (with ADC value of 1.3–1.4 · 103 cm2/s) was calculated
in ﬁve lesions. The rest of the lesions (53 lesions) showed noand well-deﬁned partially obscured opacities proved by US to be
rmed its benign nature. (a) T2 fat suppressed axial image revealed
age revealed type I curve pattern, while the ADC map (c) revealed
Table 2 Diffusion weighted imaging values for detected focal mass lesions.
Focal mass lesions Total
Benign Malignant Borderline
Non-restricted (>1.4 · 103 mm2/s) 51 2 – 53
Borderline restriction (1.3–1.4 · 103 mm2/s) 4 – 1 5
Restricted (<1.3 · 103 mm2/s) 2 43 – 45
Total 57 45 1 103
Figure 2 Sixty ﬁve years old menopausal female with the left breast asymmetry, inﬁltrative lesion on US and left axillary nodes with lost
hilum and desmoplastic reaction, FNAC revealed granulomatous mastitis which was inconsistent with the MRM ﬁndings, re-biopsy, core
type, revealed lobular carcinomatosis. T1 (a) and T2 fat suppressed (b) axial images revealing the left breast T1 and T2 hypointense lesions
surrounded by edema reaching deep into the underlying pectoralis muscle appreciated on T2 fat suppressed image, diffusion analysis with
ADC map (c) and b-800 value DWI (d), showing marked diffusion restriction (hypointense on ADC map and hyperintense on DWI),
followed by the ADC values (e) of the lesion which was <1.3 · 103 mm2/s), while (f) is post-contrast subtracted images showing type III
rapid wash in wash out enhancement curve.
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3 · 103 cm2/s (Fig. 1).
Out of the 45 lesions with restricted diffusion 43 proved to
be malignant mass lesions, while the other two were benign le-
sions which proved to be inﬂammatory in origin with the
breast abscess formation which was the scope of the ADC
reading, for cases with borderline restriction, four proved to
be benign while the remaining one proved to be borderline (cel-
lular atypia). As for the remaining 53 non-restricted lesions,
only two were already known as malignant lesions and were
on chemotherapy, while the remaining 51 proved to be benign
on histo-pathological analysis (Table 2) (Fig. 2).
Comparing the enhancement kinetics with the ADC values
one noticed that four cases with progressive enhancement
curve showed restricted diffusion, which proved to be malig-
nant, four cases with borderline diffusion proved to be benign
on histo-pathological analysis. Adding diffusion analysis to the
fore mentioned enhancement kinetics criterion the sensitivity
jumped from 86.95% up to 93.47% and the speciﬁcity from
91.22% to 96.49% in detection of malignancy with PPV of
95.55% in comparison to 86.66% for enhancement kinetics
alone. Both speciﬁcity and PPV would be changed up to
100% respectively if the two breast abscesses were excluded
since they are not true focal solid lesions. Furthermore, sensi-Figure 3 A 42 years old female with family history of breast cance
axillary lump, altered texture but still no masses were identiﬁed on US
localization and biopsy revealed DCIS with invasive component (a): a
non-mass enhancement and level I axillary node, (b) post-processed sub
along the node, diffusion analysis with b-800 value DWI (c) and ADC
and hyperintense on DWI), showing ADC values of <1.3 · 103 mmtivity would rise up to 97.72% instead of just 93.47% if we ex-
clude the already known cases of malignancy.
Lymph nodes were detected in all cases, where 32 showed
lost/eccentric hilum cases, 29 showed globular shape, three
had inﬁltration into the surrounding tissue, one with central
necrosis, 24 cases exhibited restricted diffusion ranging from
0.5 to 1 · 103 cm2/ s (<1.3 · 103 cm2/ s), where 35 proved
to be malignant and 36 benign on histo-pathology (Fig. 3).
4. Discussion
Reviewing the study’s results we agreed with previous studies
that MRI was superior to ultrasonography in detecting addi-
tional lesions mounting up to 21.35% (22/103), which concurs
with the widely accepted concept that MRM is an established
technique for improving the sensitivity of detecting breast
cancer.21,22,23
However, breast MRI is still ﬂawed for its relative low spec-
iﬁcity compared to mammography and ultrasonography. Gen-
erally, several diverse techniques for breast MRI are used in a
trial to overcome such drawback. Our study focused on the ba-
sic conventional dynamic-enhanced MRI which as previously
mentioned increased sensitivity of detecting breast lesions in
general, and added the DWI sequence testing its feasibilityr and microcalciﬁcation on follow-up (high risk) developed right
, MRM revealed enhancing focus, still irreproducible on US, wire
xial MIP image showing enhancing focus surrounded by clumped
tracted enhanced image showing type III wash in wash out pattern
map (d) showing diffusion restriction (hypointense on ADC map
2/s) of the right axillary nodes.
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breast lesions as benign or malignant.
Summing up our diffusion analysis results; sensitivity was
93.47%, speciﬁcity 96.49% and PPV was 95.55% for malig-
nancy detection, which concurred with several other studies.
In 2009, Kim et al. found the cancer detection rate for DWI
was 92% in their study of 67 tumors, where DWI was able to
detect mammographically and clinically occult breast
carcinomas.24
Moreover, the performance of DWI to discriminate be-
tween benign and latent tumors also is very good, according
to a 2009 study by Yili et al. The research had accuracy as high
as 97% in differentiating benign from malignant lesions.15
Other studies used a lower ADC value threshold of
1.13 · 103 mm2/s as Tozaki et al. yielded a speciﬁcity of
67% (43/64) and sensitivity of 97% (61/63) for focal mass le-
sions, regardless of the lesion size.20
Such low speciﬁcity differed from ours due to the fact that
we used a higher ADC cut off value, while sensitivity did not
vary to that extent, which upgraded our cut off value and
proved its signiﬁcant higher accuracy.
Same conﬂict was faced when using a higher ADC cut off
value as did Partridge et al. by applying an ADC threshold
of 1.81 · 103 mm2/s for 100% sensitivity but produced a
PPV of 47%, therefore, the stress of biopsying benign lesions
increased, since many benign lesions exhibited ADC values be-
low this cut off and therefore, they were regarded as suspicious
by DCE-MRI and obviously by the high ADC cut off value
suggested on DWI.17
Analyzing the study’s results we would ﬁnd that a total of
12 cases would be misplaced depending on the enhancement
criterion alone.
Six cases with type III curve proved to be benign by biopsy,
adding the DWI sequence with its ADC threshold to the
assessment increased the PPV over DCE-MRI alone and
would have prevented biopsy for those cases which account
for 6/57 (10.5%) of benign lesions and 6/103 (5.82%) of the to-
tal number of lesions studied. The other six cases would have
been missed as benign which is reﬂected in the sensitivity val-
ues difference.
In theory, if we omit the two complicated cysts with dif-
fusion restriction since we should consider them as benign
based on other criteria such as signal characteristics and
the fact that they are liqueﬁed rather than solid focal le-
sions, we would have both speciﬁcity and PPV surge to
100%, respectively.
On the other hand, the false negative lesions on DWI, were
already on chemotherapy and non-restriction actually reﬂected
the tumor response on a biological level to treatment, again
excluding them from the calculations as they do not ﬁt the cri-
teria of being newly discovered lesions waiting to be classiﬁed,
and the fact that they are biologically altered sequel to external
factors, would raise the sensitivity of up to 97.72% instead of
just 93.47%, taking into consideration that the false negative
lesion by diffusion proved on histo-pathological analysis to
be ﬁbroadenoma with atypia (borderline), which should not
be considered as frank malignancy in the ﬁrst place. Hence fur-
ther studies should be carried out to test the potential of diffu-
sion weighted imaging and the use of ADC values in
monitoring the response of cases with breast cancer on chemo-
therapy rather than considering it as a drawback of the current
study.Trying to explain the fact; that histo-pathologically border-
line lesions might give non-restricted ADC values; DWI pro-
vides biological information about the composition of
tissues, their physical properties, their microstructure and their
architectural organization, which might not be at all disturbed
to the extent that they might reﬂect on the DWI readings.25
Furthermore, DWI was found to be useful in detecting af-
fected lymph nodes in conjunction to shape criterion, since three
out of the 24 nodes showing restricted diffusion actually hadpre-
served hilum which aids in identifying nodal affection earlier by
biological behavior rather than waiting for morphological
changes which reﬂects on the choice of line of treatment.
As for the size criterion of the lesions, we did not give it
much weight, as our lesions’ size was above 5 mm, which is
sometimes used as a threshold of detection, since the ROI of
assessment might include the neighboring tissue if less than
that, which subsequently might give inaccurate, falsiﬁed read-
ings. According to Partridge et al., whose study excluded foci,
the difference in diagnostic performance of DWI for these very
small (<5 mm) lesions was not evaluated, as it was likely that
the ADCs of foci were affected by the limited spatial resolution
of DWI. Both, his study and ours, warrant further investiga-
tion of this area.19
Though our work was performed on a 1.5 T MRI machine,
still our results concur with other studies, even those per-
formed on 3 T machines. Matsuoka and colleagues evaluated
16 lesions and 13 patients who underwent MRI exams with
both magnet strengths. The study found no signiﬁcant differ-
ence for ADC values between the two MRI devices, the lesions
less than 10 mm in size were more clearly visible and better
delineated at 3 T. However, researchers noted that the exam
protocol varied in this study, with thinner image slices ac-
quired with 3 T compared with 1.5 T.26
5. Conclusion
Our data were comparable to others with no signiﬁcant impact
from the population pool. DWI revealed to increase the spec-
iﬁcity for breast tumors detection in comparison to conven-
tional MRI, with subsequent decrease in the rate of
additional unnecessary biopsies. Still DWI should be per-
formed in conjunction with contrast-enhanced MRI because
it is evident that small breast lesions as well as non-mass
enhancement are not seen on DWI.
Furthermore, DWI shows a promising potential for moni-
toring the response to chemotherapy even before the post-
treatment morphological changes, further studies are advised
to prove such hypothesis.
References
1. D’Orsi CJ. Breast imaging. Radiol Clin N Am 2004;42:xi–xii.
2. Bluemke DA, Gatsonis CA, Chen MH, DeAngelis GA, DeBruhl
S, Harms S, et al. Magnetic resonance imaging of the breast prior
to biopsy. JAMA 2004;292:2735–42.
3. Liberman L, Morris EA, Dershaw DD, Abramson AF, Tan LK.
MR imaging of the ipsilateral breast in women with percutane-
ously proven breast cancer. AJR Am J Roentgenol
2003;180:901–10.
4. Bone B, Pentek Z, Perbeck L, Veress B. Diagnostic accuracy of
mammography and contrast-enhanced MR imaging in 238 histo-
logically veriﬁed breast lesions. Acta Radiol 1997;38:489–96.
272 H.H.M. Hassan et al.5. Kuhl CK, Schmutzler R, Leutner CC. Breast MR imaging
screening in 192 women proved or suspected to be carriers of a
breast cancer susceptibility gene: preliminary results. Radiology
2000;215:267–79.
6. Liberman L, Morris EA, Lee MJY. Breast lesions detected on MR
imaging: features and positive predictive value. AJR 2002;179:
171–8.
7. Kelcz F, Furman-Haran E, Grobgeld D, Degani H. Clinical
testing of high-spatial-resolution parametric contrast-enhanced
MR imaging of the breast. AJR 2002;179:1485–92.
8. Orel SG, Schnall MD. MR imaging of the breast for the detection,
diagnosis and staging of breast cancer. Radiology 2001;220:13–30.
9. Wiener JI, Schilling KJ, Adami C, Obuchowski NA. Assessment
of suspected breast cancer by MRI: a prospective clinical trial
using a combined kinetic and morphologic analysis. AJR
2005;184:878–86.
10. Bammer R. Basic principles of diffusion-weighted imaging. Eur J
Radiol 2003;45:169–84.
11. Koh D-M, Collins DJ. Diffusion-weighted MRI in the body:
applications and challenges in oncology. AJR 2007;188:1622–35.
12. Palle L, Reddy B. Role of diffusion MRI in characterizing benign
and malignant breast lesions. Indian J Radiol Imaging 2009;19(4):
287–90.
13. Park MJ, Cha ES, Kang BJ, Ihn YK, Baik JH. The role of
diffusion-weighted imaging and the apparent diffusion coefﬁcient
(ADC) values for breast tumors. Korean J Radiol 2007;8(5):390–6.
14. Woodhams R, Matsunaga K, Kan S, Hata H, Ozaki M, Iwabuchi
K, et al. ADC mapping of benign and malignant breast tumors.
Magn Reso Med Sci 2005;4(1):35–42.
15. Yili Z, Xiaoyan H, Hongwen D, Yun Z, Xin C, Peng W, et al. The
value of diffusion-weighted imaging in assessing the ADC changes
of tissues adjacent to breast carcinoma. BMC Cancer 2009;9:18.
16. Choi SY, Chang Y-W, Park HJ, Kim HJ, Hong SS, Seo DY.
Correlation of diffusion-weighted imaging apparent diffusion
coefﬁcient with prognostic factors of breast cancer. Br J Radiol
2012;85:474–9.
17. Partridge SC, DeMartini WB, Kurland BF, Eby PR, White SW,
Lehman CD. Quantitative diffusion-weighted imaging as anadjunct to conventional breast MRI for improved positive
predictive value. AJR 2009;193:1716–22.
18. Kul S, Cansu A, Alhan E, Dinc H, Gunes G, Reis A. Contribution
of diffusion-weighted imaging to dynamic contrast-enhanced MRI
in the characterization of breast tumors. AJR 2011;196(1):210–7.
19. Partridge SC, Mullins CD, Kurland BF, Allain MD, DeMartini
PR, Eby PR, et al. Apparent diffusion coefﬁcient values for
discriminating benign and malignant breast MRI lesions: effects of
lesion type and size. AJR 2010;194:1664–73.
20. Tozaki M, Fukuma E. 1H MR spectroscopy and diffusion-
weighted imaging of the breast: are they useful tools for
characterizing breast lesions before biopsy? AJR
2009;193:840–9.
21. Park MJ, Cha ES, Kang BJ, Ihn YK, Baik JH. The role of
diffusion-weighted imaging and the apparent diffusion coefﬁ-
cient (ADC) values for breast tumors. Korean J Radiol
2007;8(5):390–6.
22. Siegmann KC, Muller-Schimpﬂe M, Schick F, Remy CT, Fersis
P, Ruck P, et al. MR imaging-detected breast lesion: histopath-
ologic correlation of lesion characteristics and signal intensity
data. AJR Am J Roentgenol 2002;178:1403–9.
23. Jacobs MA, Barker PB, Bluemke DA, Maranto C, Arnold C,
Herskovits EH, et al. Benign and malignant breast lesions:
diagnosis with multiparametric MR imaging. Radiology
2003;229:225–32.
24. Kim SH, Cha ES, Kim HS, Kang BJ, Choi JJ, Jung JH, et al.
Diffusion-weighted imaging of breast cancer: correlation of the
apparent diffusion coefﬁcient value with prognostic factors. J
Magn Reson Imaging 2009;3(30):615–20.
25. Basser PJ. Diffusion and diffusion tensor imaging. In: Atlas SW,
editor. Magnetic resonance imaging of brain and spine. 3rd
ed. Philadelphia: Lippincot Williams and Wilkins; 2002. p.
197–212.
26. Matsuoka A, Minato M, Harada M, Kubo H, Bandou Y,
Tangoku A, et al. Comparison of 3.0- and 1.5-T diffusion-
weighted imaging in the visibility of breast cancer. Radiat Med
2008;26(1):15–20.
